Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007398
Filing Date
2022-05-05
Accepted
2022-05-05 16:25:56
Documents
43
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20220331x10q.htm   iXBRL 10-Q 722158
2 EX-10.2 gbio-20220331xex10d2.htm EX-10.2 114369
3 EX-31.1 gbio-20220331xex31d1.htm EX-31.1 7409
4 EX-31.2 gbio-20220331xex31d2.htm EX-31.2 7548
5 EX-32.1 gbio-20220331xex32d1.htm EX-32.1 5111
6 EX-32.2 gbio-20220331xex32d2.htm EX-32.2 5090
  Complete submission text file 0001558370-22-007398.txt   2754808

Data Files

Seq Description Document Type Size
7 EX-101.SCH gbio-20220331.xsd EX-101.SCH 19525
8 EX-101.CAL gbio-20220331_cal.xml EX-101.CAL 27155
9 EX-101.DEF gbio-20220331_def.xml EX-101.DEF 76363
10 EX-101.LAB gbio-20220331_lab.xml EX-101.LAB 176555
11 EX-101.PRE gbio-20220331_pre.xml EX-101.PRE 147858
37 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20220331x10q_htm.xml XML 251509
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 22896755
SIC: 2834 Pharmaceutical Preparations